Cargando…
Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer
Although oxaliplatin is an effective chemotherapeutic drug for treatment of colorectal cancer (CRC), tumor cells can develop mechanisms to evade oxaliplatin-induced cell death and show high tolerance and acquired resistance to this drug. Heterogeneous nuclear ribonucleoprotein L (hnRNP L) has been p...
Autores principales: | Hu, Wenjun, Lei, Linping, Xie, Xuqin, Huang, Libin, Cui, Qian, Dang, Tang, Liu, Gang Logan, Li, Yuan, Sun, Xiaofeng, Zhou, Zongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639419/ https://www.ncbi.nlm.nih.gov/pubmed/31320608 http://dx.doi.org/10.1038/s41419-019-1784-x |
Ejemplares similares
-
Replicated chromatin curtails 53BP1 recruitment in BRCA1-proficient and BRCA1-deficient cells
por: Michelena, Jone, et al.
Publicado: (2021) -
HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1
por: Xia, Renpeng, et al.
Publicado: (2023) -
Spatiotemporal dynamics of 53BP1 dimer recruitment to a DNA double strand break
por: Lou, Jieqiong, et al.
Publicado: (2020) -
PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1
por: Belotserkovskaya, Rimma, et al.
Publicado: (2020) -
ZMYM2 restricts 53BP1 at DNA double-strand breaks to favor BRCA1 loading and homologous recombination
por: Lee, Doohyung, et al.
Publicado: (2022)